ArticleInternational journal of molecular sciences2024

PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative Breast Cancer.

Shih-Ho Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.